Global AI-driven Drug Discovery Market Research Report 2024, Forecast to 2032
Report Overview
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global AI-driven Drug Discovery market size was estimated at USD 716 million in 2023 and is projected to reach USD 1758.63 million by 2032, exhibiting a CAGR of 10.50% during the forecast period.
North America AI-driven Drug Discovery market size was estimated at USD 221.66 million in 2023, at a CAGR of 9.00% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global AI-driven Drug Discovery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global AI-driven Drug Discovery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the AI-driven Drug Discovery market in any manner.
Global AI-driven Drug Discovery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Market Segmentation (by Type)
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research Laboratories
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI-driven Drug Discovery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI-driven Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global AI-driven Drug Discovery market size was estimated at USD 716 million in 2023 and is projected to reach USD 1758.63 million by 2032, exhibiting a CAGR of 10.50% during the forecast period.
North America AI-driven Drug Discovery market size was estimated at USD 221.66 million in 2023, at a CAGR of 9.00% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global AI-driven Drug Discovery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global AI-driven Drug Discovery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the AI-driven Drug Discovery market in any manner.
Global AI-driven Drug Discovery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Market Segmentation (by Type)
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the AI-driven Drug Discovery Market
- Overview of the regional outlook of the AI-driven Drug Discovery Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI-driven Drug Discovery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI-driven Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of AI-driven Drug Discovery
1.2 Key Market Segments
1.2.1 AI-driven Drug Discovery Segment by Type
1.2.2 AI-driven Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI-DRIVEN DRUG DISCOVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global AI-driven Drug Discovery Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI-DRIVEN DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE
3.1 Global AI-driven Drug Discovery Sales by Manufacturers (2019-2024)
3.2 Global AI-driven Drug Discovery Revenue Market Share by Manufacturers (2019-2024)
3.3 AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global AI-driven Drug Discovery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers AI-driven Drug Discovery Sales Sites, Area Served, Product Type
3.6 AI-driven Drug Discovery Market Competitive Situation and Trends
3.6.1 AI-driven Drug Discovery Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI-driven Drug Discovery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS
4.1 AI-driven Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI-DRIVEN DRUG DISCOVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI-driven Drug Discovery Sales Market Share by Type (2019-2024)
6.3 Global AI-driven Drug Discovery Market Size Market Share by Type (2019-2024)
6.4 Global AI-driven Drug Discovery Price by Type (2019-2024)
7 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI-driven Drug Discovery Market Sales by Application (2019-2024)
7.3 Global AI-driven Drug Discovery Market Size (M USD) by Application (2019-2024)
7.4 Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
8 AI-DRIVEN DRUG DISCOVERY MARKET CONSUMPTION BY REGION
8.1 Global AI-driven Drug Discovery Sales by Region
8.1.1 Global AI-driven Drug Discovery Sales by Region
8.1.2 Global AI-driven Drug Discovery Sales Market Share by Region
8.2 North America
8.2.1 North America AI-driven Drug Discovery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI-driven Drug Discovery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific AI-driven Drug Discovery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI-driven Drug Discovery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI-driven Drug Discovery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 AI-DRIVEN DRUG DISCOVERY MARKET PRODUCTION BY REGION
9.1 Global Production of AI-driven Drug Discovery by Region (2019-2024)
9.2 Global AI-driven Drug Discovery Revenue Market Share by Region (2019-2024)
9.3 Global AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America AI-driven Drug Discovery Production
9.4.1 North America AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.4.2 North America AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe AI-driven Drug Discovery Production
9.5.1 Europe AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.5.2 Europe AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan AI-driven Drug Discovery Production (2019-2024)
9.6.1 Japan AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.6.2 Japan AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China AI-driven Drug Discovery Production (2019-2024)
9.7.1 China AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.7.2 China AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Entos
10.1.1 Entos AI-driven Drug Discovery Basic Information
10.1.2 Entos AI-driven Drug Discovery Product Overview
10.1.3 Entos AI-driven Drug Discovery Product Market Performance
10.1.4 Entos Business Overview
10.1.5 Entos AI-driven Drug Discovery SWOT Analysis
10.1.6 Entos Recent Developments
10.2 Selvita
10.2.1 Selvita AI-driven Drug Discovery Basic Information
10.2.2 Selvita AI-driven Drug Discovery Product Overview
10.2.3 Selvita AI-driven Drug Discovery Product Market Performance
10.2.4 Selvita Business Overview
10.2.5 Selvita AI-driven Drug Discovery SWOT Analysis
10.2.6 Selvita Recent Developments
10.3 Benevolent
10.3.1 Benevolent AI-driven Drug Discovery Basic Information
10.3.2 Benevolent AI-driven Drug Discovery Product Overview
10.3.3 Benevolent AI-driven Drug Discovery Product Market Performance
10.3.4 Benevolent AI-driven Drug Discovery SWOT Analysis
10.3.5 Benevolent Business Overview
10.3.6 Benevolent Recent Developments
10.4 Exscientia
10.4.1 Exscientia AI-driven Drug Discovery Basic Information
10.4.2 Exscientia AI-driven Drug Discovery Product Overview
10.4.3 Exscientia AI-driven Drug Discovery Product Market Performance
10.4.4 Exscientia Business Overview
10.4.5 Exscientia Recent Developments
10.5 Euretos
10.5.1 Euretos AI-driven Drug Discovery Basic Information
10.5.2 Euretos AI-driven Drug Discovery Product Overview
10.5.3 Euretos AI-driven Drug Discovery Product Market Performance
10.5.4 Euretos Business Overview
10.5.5 Euretos Recent Developments
10.6 Illumina with AstraZeneca
10.6.1 Illumina with AstraZeneca AI-driven Drug Discovery Basic Information
10.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
10.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product Market Performance
10.6.4 Illumina with AstraZeneca Business Overview
10.6.5 Illumina with AstraZeneca Recent Developments
10.7 Novo Nordisk with Microsoft
10.7.1 Novo Nordisk with Microsoft AI-driven Drug Discovery Basic Information
10.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
10.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Market Performance
10.7.4 Novo Nordisk with Microsoft Business Overview
10.7.5 Novo Nordisk with Microsoft Recent Developments
10.8 Iktos
10.8.1 Iktos AI-driven Drug Discovery Basic Information
10.8.2 Iktos AI-driven Drug Discovery Product Overview
10.8.3 Iktos AI-driven Drug Discovery Product Market Performance
10.8.4 Iktos Business Overview
10.8.5 Iktos Recent Developments
10.9 Aqemia
10.9.1 Aqemia AI-driven Drug Discovery Basic Information
10.9.2 Aqemia AI-driven Drug Discovery Product Overview
10.9.3 Aqemia AI-driven Drug Discovery Product Market Performance
10.9.4 Aqemia Business Overview
10.9.5 Aqemia Recent Developments
10.10 Zephyr AI
10.10.1 Zephyr AI AI-driven Drug Discovery Basic Information
10.10.2 Zephyr AI AI-driven Drug Discovery Product Overview
10.10.3 Zephyr AI AI-driven Drug Discovery Product Market Performance
10.10.4 Zephyr AI Business Overview
10.10.5 Zephyr AI Recent Developments
10.11 Cyclicarx
10.11.1 Cyclicarx AI-driven Drug Discovery Basic Information
10.11.2 Cyclicarx AI-driven Drug Discovery Product Overview
10.11.3 Cyclicarx AI-driven Drug Discovery Product Market Performance
10.11.4 Cyclicarx Business Overview
10.11.5 Cyclicarx Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly AI-driven Drug Discovery Basic Information
10.12.2 Eli Lilly AI-driven Drug Discovery Product Overview
10.12.3 Eli Lilly AI-driven Drug Discovery Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Terray Therapeutics
10.13.1 Terray Therapeutics AI-driven Drug Discovery Basic Information
10.13.2 Terray Therapeutics AI-driven Drug Discovery Product Overview
10.13.3 Terray Therapeutics AI-driven Drug Discovery Product Market Performance
10.13.4 Terray Therapeutics Business Overview
10.13.5 Terray Therapeutics Recent Developments
10.14 Ardigen
10.14.1 Ardigen AI-driven Drug Discovery Basic Information
10.14.2 Ardigen AI-driven Drug Discovery Product Overview
10.14.3 Ardigen AI-driven Drug Discovery Product Market Performance
10.14.4 Ardigen Business Overview
10.14.5 Ardigen Recent Developments
10.15 ReviveMed
10.15.1 ReviveMed AI-driven Drug Discovery Basic Information
10.15.2 ReviveMed AI-driven Drug Discovery Product Overview
10.15.3 ReviveMed AI-driven Drug Discovery Product Market Performance
10.15.4 ReviveMed Business Overview
10.15.5 ReviveMed Recent Developments
10.16 Insilico Medicine
10.16.1 Insilico Medicine AI-driven Drug Discovery Basic Information
10.16.2 Insilico Medicine AI-driven Drug Discovery Product Overview
10.16.3 Insilico Medicine AI-driven Drug Discovery Product Market Performance
10.16.4 Insilico Medicine Business Overview
10.16.5 Insilico Medicine Recent Developments
10.17 XtalPi
10.17.1 XtalPi AI-driven Drug Discovery Basic Information
10.17.2 XtalPi AI-driven Drug Discovery Product Overview
10.17.3 XtalPi AI-driven Drug Discovery Product Market Performance
10.17.4 XtalPi Business Overview
10.17.5 XtalPi Recent Developments
10.18 MindRank
10.18.1 MindRank AI-driven Drug Discovery Basic Information
10.18.2 MindRank AI-driven Drug Discovery Product Overview
10.18.3 MindRank AI-driven Drug Discovery Product Market Performance
10.18.4 MindRank Business Overview
10.18.5 MindRank Recent Developments
10.19 DP Technology
10.19.1 DP Technology AI-driven Drug Discovery Basic Information
10.19.2 DP Technology AI-driven Drug Discovery Product Overview
10.19.3 DP Technology AI-driven Drug Discovery Product Market Performance
10.19.4 DP Technology Business Overview
10.19.5 DP Technology Recent Developments
11 AI-DRIVEN DRUG DISCOVERY MARKET FORECAST BY REGION
11.1 Global AI-driven Drug Discovery Market Size Forecast
11.2 Global AI-driven Drug Discovery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AI-driven Drug Discovery Market Size Forecast by Country
11.2.3 Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region
11.2.4 South America AI-driven Drug Discovery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of AI-driven Drug Discovery by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global AI-driven Drug Discovery Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of AI-driven Drug Discovery by Type (2025-2032)
12.1.2 Global AI-driven Drug Discovery Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of AI-driven Drug Discovery by Type (2025-2032)
12.2 Global AI-driven Drug Discovery Market Forecast by Application (2025-2032)
12.2.1 Global AI-driven Drug Discovery Sales (K Units) Forecast by Application
12.2.2 Global AI-driven Drug Discovery Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of AI-driven Drug Discovery
1.2 Key Market Segments
1.2.1 AI-driven Drug Discovery Segment by Type
1.2.2 AI-driven Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI-DRIVEN DRUG DISCOVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global AI-driven Drug Discovery Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI-DRIVEN DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE
3.1 Global AI-driven Drug Discovery Sales by Manufacturers (2019-2024)
3.2 Global AI-driven Drug Discovery Revenue Market Share by Manufacturers (2019-2024)
3.3 AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global AI-driven Drug Discovery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers AI-driven Drug Discovery Sales Sites, Area Served, Product Type
3.6 AI-driven Drug Discovery Market Competitive Situation and Trends
3.6.1 AI-driven Drug Discovery Market Concentration Rate
3.6.2 Global 5 and 10 Largest AI-driven Drug Discovery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS
4.1 AI-driven Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI-DRIVEN DRUG DISCOVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI-driven Drug Discovery Sales Market Share by Type (2019-2024)
6.3 Global AI-driven Drug Discovery Market Size Market Share by Type (2019-2024)
6.4 Global AI-driven Drug Discovery Price by Type (2019-2024)
7 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI-driven Drug Discovery Market Sales by Application (2019-2024)
7.3 Global AI-driven Drug Discovery Market Size (M USD) by Application (2019-2024)
7.4 Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
8 AI-DRIVEN DRUG DISCOVERY MARKET CONSUMPTION BY REGION
8.1 Global AI-driven Drug Discovery Sales by Region
8.1.1 Global AI-driven Drug Discovery Sales by Region
8.1.2 Global AI-driven Drug Discovery Sales Market Share by Region
8.2 North America
8.2.1 North America AI-driven Drug Discovery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AI-driven Drug Discovery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific AI-driven Drug Discovery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AI-driven Drug Discovery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AI-driven Drug Discovery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 AI-DRIVEN DRUG DISCOVERY MARKET PRODUCTION BY REGION
9.1 Global Production of AI-driven Drug Discovery by Region (2019-2024)
9.2 Global AI-driven Drug Discovery Revenue Market Share by Region (2019-2024)
9.3 Global AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America AI-driven Drug Discovery Production
9.4.1 North America AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.4.2 North America AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe AI-driven Drug Discovery Production
9.5.1 Europe AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.5.2 Europe AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan AI-driven Drug Discovery Production (2019-2024)
9.6.1 Japan AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.6.2 Japan AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China AI-driven Drug Discovery Production (2019-2024)
9.7.1 China AI-driven Drug Discovery Production Growth Rate (2019-2024)
9.7.2 China AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Entos
10.1.1 Entos AI-driven Drug Discovery Basic Information
10.1.2 Entos AI-driven Drug Discovery Product Overview
10.1.3 Entos AI-driven Drug Discovery Product Market Performance
10.1.4 Entos Business Overview
10.1.5 Entos AI-driven Drug Discovery SWOT Analysis
10.1.6 Entos Recent Developments
10.2 Selvita
10.2.1 Selvita AI-driven Drug Discovery Basic Information
10.2.2 Selvita AI-driven Drug Discovery Product Overview
10.2.3 Selvita AI-driven Drug Discovery Product Market Performance
10.2.4 Selvita Business Overview
10.2.5 Selvita AI-driven Drug Discovery SWOT Analysis
10.2.6 Selvita Recent Developments
10.3 Benevolent
10.3.1 Benevolent AI-driven Drug Discovery Basic Information
10.3.2 Benevolent AI-driven Drug Discovery Product Overview
10.3.3 Benevolent AI-driven Drug Discovery Product Market Performance
10.3.4 Benevolent AI-driven Drug Discovery SWOT Analysis
10.3.5 Benevolent Business Overview
10.3.6 Benevolent Recent Developments
10.4 Exscientia
10.4.1 Exscientia AI-driven Drug Discovery Basic Information
10.4.2 Exscientia AI-driven Drug Discovery Product Overview
10.4.3 Exscientia AI-driven Drug Discovery Product Market Performance
10.4.4 Exscientia Business Overview
10.4.5 Exscientia Recent Developments
10.5 Euretos
10.5.1 Euretos AI-driven Drug Discovery Basic Information
10.5.2 Euretos AI-driven Drug Discovery Product Overview
10.5.3 Euretos AI-driven Drug Discovery Product Market Performance
10.5.4 Euretos Business Overview
10.5.5 Euretos Recent Developments
10.6 Illumina with AstraZeneca
10.6.1 Illumina with AstraZeneca AI-driven Drug Discovery Basic Information
10.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
10.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product Market Performance
10.6.4 Illumina with AstraZeneca Business Overview
10.6.5 Illumina with AstraZeneca Recent Developments
10.7 Novo Nordisk with Microsoft
10.7.1 Novo Nordisk with Microsoft AI-driven Drug Discovery Basic Information
10.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
10.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Market Performance
10.7.4 Novo Nordisk with Microsoft Business Overview
10.7.5 Novo Nordisk with Microsoft Recent Developments
10.8 Iktos
10.8.1 Iktos AI-driven Drug Discovery Basic Information
10.8.2 Iktos AI-driven Drug Discovery Product Overview
10.8.3 Iktos AI-driven Drug Discovery Product Market Performance
10.8.4 Iktos Business Overview
10.8.5 Iktos Recent Developments
10.9 Aqemia
10.9.1 Aqemia AI-driven Drug Discovery Basic Information
10.9.2 Aqemia AI-driven Drug Discovery Product Overview
10.9.3 Aqemia AI-driven Drug Discovery Product Market Performance
10.9.4 Aqemia Business Overview
10.9.5 Aqemia Recent Developments
10.10 Zephyr AI
10.10.1 Zephyr AI AI-driven Drug Discovery Basic Information
10.10.2 Zephyr AI AI-driven Drug Discovery Product Overview
10.10.3 Zephyr AI AI-driven Drug Discovery Product Market Performance
10.10.4 Zephyr AI Business Overview
10.10.5 Zephyr AI Recent Developments
10.11 Cyclicarx
10.11.1 Cyclicarx AI-driven Drug Discovery Basic Information
10.11.2 Cyclicarx AI-driven Drug Discovery Product Overview
10.11.3 Cyclicarx AI-driven Drug Discovery Product Market Performance
10.11.4 Cyclicarx Business Overview
10.11.5 Cyclicarx Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly AI-driven Drug Discovery Basic Information
10.12.2 Eli Lilly AI-driven Drug Discovery Product Overview
10.12.3 Eli Lilly AI-driven Drug Discovery Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Terray Therapeutics
10.13.1 Terray Therapeutics AI-driven Drug Discovery Basic Information
10.13.2 Terray Therapeutics AI-driven Drug Discovery Product Overview
10.13.3 Terray Therapeutics AI-driven Drug Discovery Product Market Performance
10.13.4 Terray Therapeutics Business Overview
10.13.5 Terray Therapeutics Recent Developments
10.14 Ardigen
10.14.1 Ardigen AI-driven Drug Discovery Basic Information
10.14.2 Ardigen AI-driven Drug Discovery Product Overview
10.14.3 Ardigen AI-driven Drug Discovery Product Market Performance
10.14.4 Ardigen Business Overview
10.14.5 Ardigen Recent Developments
10.15 ReviveMed
10.15.1 ReviveMed AI-driven Drug Discovery Basic Information
10.15.2 ReviveMed AI-driven Drug Discovery Product Overview
10.15.3 ReviveMed AI-driven Drug Discovery Product Market Performance
10.15.4 ReviveMed Business Overview
10.15.5 ReviveMed Recent Developments
10.16 Insilico Medicine
10.16.1 Insilico Medicine AI-driven Drug Discovery Basic Information
10.16.2 Insilico Medicine AI-driven Drug Discovery Product Overview
10.16.3 Insilico Medicine AI-driven Drug Discovery Product Market Performance
10.16.4 Insilico Medicine Business Overview
10.16.5 Insilico Medicine Recent Developments
10.17 XtalPi
10.17.1 XtalPi AI-driven Drug Discovery Basic Information
10.17.2 XtalPi AI-driven Drug Discovery Product Overview
10.17.3 XtalPi AI-driven Drug Discovery Product Market Performance
10.17.4 XtalPi Business Overview
10.17.5 XtalPi Recent Developments
10.18 MindRank
10.18.1 MindRank AI-driven Drug Discovery Basic Information
10.18.2 MindRank AI-driven Drug Discovery Product Overview
10.18.3 MindRank AI-driven Drug Discovery Product Market Performance
10.18.4 MindRank Business Overview
10.18.5 MindRank Recent Developments
10.19 DP Technology
10.19.1 DP Technology AI-driven Drug Discovery Basic Information
10.19.2 DP Technology AI-driven Drug Discovery Product Overview
10.19.3 DP Technology AI-driven Drug Discovery Product Market Performance
10.19.4 DP Technology Business Overview
10.19.5 DP Technology Recent Developments
11 AI-DRIVEN DRUG DISCOVERY MARKET FORECAST BY REGION
11.1 Global AI-driven Drug Discovery Market Size Forecast
11.2 Global AI-driven Drug Discovery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AI-driven Drug Discovery Market Size Forecast by Country
11.2.3 Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region
11.2.4 South America AI-driven Drug Discovery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of AI-driven Drug Discovery by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global AI-driven Drug Discovery Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of AI-driven Drug Discovery by Type (2025-2032)
12.1.2 Global AI-driven Drug Discovery Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of AI-driven Drug Discovery by Type (2025-2032)
12.2 Global AI-driven Drug Discovery Market Forecast by Application (2025-2032)
12.2.1 Global AI-driven Drug Discovery Sales (K Units) Forecast by Application
12.2.2 Global AI-driven Drug Discovery Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. AI-driven Drug Discovery Market Size Comparison by Region (M USD)
Table 5. Global AI-driven Drug Discovery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global AI-driven Drug Discovery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global AI-driven Drug Discovery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global AI-driven Drug Discovery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2022)
Table 10. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers AI-driven Drug Discovery Sales Sites and Area Served
Table 12. Manufacturers AI-driven Drug Discovery Product Type
Table 13. Global AI-driven Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of AI-driven Drug Discovery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. AI-driven Drug Discovery Market Challenges
Table 22. Global AI-driven Drug Discovery Sales by Type (K Units)
Table 23. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 24. Global AI-driven Drug Discovery Sales (K Units) by Type (2019-2024)
Table 25. Global AI-driven Drug Discovery Sales Market Share by Type (2019-2024)
Table 26. Global AI-driven Drug Discovery Market Size (M USD) by Type (2019-2024)
Table 27. Global AI-driven Drug Discovery Market Size Share by Type (2019-2024)
Table 28. Global AI-driven Drug Discovery Price (USD/Unit) by Type (2019-2024)
Table 29. Global AI-driven Drug Discovery Sales (K Units) by Application
Table 30. Global AI-driven Drug Discovery Market Size by Application
Table 31. Global AI-driven Drug Discovery Sales by Application (2019-2024) & (K Units)
Table 32. Global AI-driven Drug Discovery Sales Market Share by Application (2019-2024)
Table 33. Global AI-driven Drug Discovery Sales by Application (2019-2024) & (M USD)
Table 34. Global AI-driven Drug Discovery Market Share by Application (2019-2024)
Table 35. Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
Table 36. Global AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 37. Global AI-driven Drug Discovery Sales Market Share by Region (2019-2024)
Table 38. North America AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 39. Europe AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 41. South America AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 43. Global AI-driven Drug Discovery Production (K Units) by Region (2019-2024)
Table 44. Global AI-driven Drug Discovery Revenue (US$ Million) by Region (2019-2024)
Table 45. Global AI-driven Drug Discovery Revenue Market Share by Region (2019-2024)
Table 46. Global AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Entos AI-driven Drug Discovery Basic Information
Table 52. Entos AI-driven Drug Discovery Product Overview
Table 53. Entos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Entos Business Overview
Table 55. Entos AI-driven Drug Discovery SWOT Analysis
Table 56. Entos Recent Developments
Table 57. Selvita AI-driven Drug Discovery Basic Information
Table 58. Selvita AI-driven Drug Discovery Product Overview
Table 59. Selvita AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Selvita Business Overview
Table 61. Selvita AI-driven Drug Discovery SWOT Analysis
Table 62. Selvita Recent Developments
Table 63. Benevolent AI-driven Drug Discovery Basic Information
Table 64. Benevolent AI-driven Drug Discovery Product Overview
Table 65. Benevolent AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Benevolent AI-driven Drug Discovery SWOT Analysis
Table 67. Benevolent Business Overview
Table 68. Benevolent Recent Developments
Table 69. Exscientia AI-driven Drug Discovery Basic Information
Table 70. Exscientia AI-driven Drug Discovery Product Overview
Table 71. Exscientia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Exscientia Business Overview
Table 73. Exscientia Recent Developments
Table 74. Euretos AI-driven Drug Discovery Basic Information
Table 75. Euretos AI-driven Drug Discovery Product Overview
Table 76. Euretos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Euretos Business Overview
Table 78. Euretos Recent Developments
Table 79. Illumina with AstraZeneca AI-driven Drug Discovery Basic Information
Table 80. Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
Table 81. Illumina with AstraZeneca AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Illumina with AstraZeneca Business Overview
Table 83. Illumina with AstraZeneca Recent Developments
Table 84. Novo Nordisk with Microsoft AI-driven Drug Discovery Basic Information
Table 85. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
Table 86. Novo Nordisk with Microsoft AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Novo Nordisk with Microsoft Business Overview
Table 88. Novo Nordisk with Microsoft Recent Developments
Table 89. Iktos AI-driven Drug Discovery Basic Information
Table 90. Iktos AI-driven Drug Discovery Product Overview
Table 91. Iktos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Iktos Business Overview
Table 93. Iktos Recent Developments
Table 94. Aqemia AI-driven Drug Discovery Basic Information
Table 95. Aqemia AI-driven Drug Discovery Product Overview
Table 96. Aqemia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Aqemia Business Overview
Table 98. Aqemia Recent Developments
Table 99. Zephyr AI AI-driven Drug Discovery Basic Information
Table 100. Zephyr AI AI-driven Drug Discovery Product Overview
Table 101. Zephyr AI AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Zephyr AI Business Overview
Table 103. Zephyr AI Recent Developments
Table 104. Cyclicarx AI-driven Drug Discovery Basic Information
Table 105. Cyclicarx AI-driven Drug Discovery Product Overview
Table 106. Cyclicarx AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Cyclicarx Business Overview
Table 108. Cyclicarx Recent Developments
Table 109. Eli Lilly AI-driven Drug Discovery Basic Information
Table 110. Eli Lilly AI-driven Drug Discovery Product Overview
Table 111. Eli Lilly AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Terray Therapeutics AI-driven Drug Discovery Basic Information
Table 115. Terray Therapeutics AI-driven Drug Discovery Product Overview
Table 116. Terray Therapeutics AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Terray Therapeutics Business Overview
Table 118. Terray Therapeutics Recent Developments
Table 119. Ardigen AI-driven Drug Discovery Basic Information
Table 120. Ardigen AI-driven Drug Discovery Product Overview
Table 121. Ardigen AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Ardigen Business Overview
Table 123. Ardigen Recent Developments
Table 124. ReviveMed AI-driven Drug Discovery Basic Information
Table 125. ReviveMed AI-driven Drug Discovery Product Overview
Table 126. ReviveMed AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. ReviveMed Business Overview
Table 128. ReviveMed Recent Developments
Table 129. Insilico Medicine AI-driven Drug Discovery Basic Information
Table 130. Insilico Medicine AI-driven Drug Discovery Product Overview
Table 131. Insilico Medicine AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Insilico Medicine Business Overview
Table 133. Insilico Medicine Recent Developments
Table 134. XtalPi AI-driven Drug Discovery Basic Information
Table 135. XtalPi AI-driven Drug Discovery Product Overview
Table 136. XtalPi AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. XtalPi Business Overview
Table 138. XtalPi Recent Developments
Table 139. MindRank AI-driven Drug Discovery Basic Information
Table 140. MindRank AI-driven Drug Discovery Product Overview
Table 141. MindRank AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. MindRank Business Overview
Table 143. MindRank Recent Developments
Table 144. DP Technology AI-driven Drug Discovery Basic Information
Table 145. DP Technology AI-driven Drug Discovery Product Overview
Table 146. DP Technology AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. DP Technology Business Overview
Table 148. DP Technology Recent Developments
Table 149. Global AI-driven Drug Discovery Sales Forecast by Region (2025-2032) & (K Units)
Table 150. Global AI-driven Drug Discovery Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 152. North America AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 154. Europe AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific AI-driven Drug Discovery Sales Forecast by Region (2025-2032) & (K Units)
Table 156. Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 158. South America AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa AI-driven Drug Discovery Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global AI-driven Drug Discovery Sales Forecast by Type (2025-2032) & (K Units)
Table 162. Global AI-driven Drug Discovery Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global AI-driven Drug Discovery Price Forecast by Type (2025-2032) & (USD/Unit)
Table 164. Global AI-driven Drug Discovery Sales (K Units) Forecast by Application (2025-2032)
Table 165. Global AI-driven Drug Discovery Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. AI-driven Drug Discovery Market Size Comparison by Region (M USD)
Table 5. Global AI-driven Drug Discovery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global AI-driven Drug Discovery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global AI-driven Drug Discovery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global AI-driven Drug Discovery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2022)
Table 10. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers AI-driven Drug Discovery Sales Sites and Area Served
Table 12. Manufacturers AI-driven Drug Discovery Product Type
Table 13. Global AI-driven Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of AI-driven Drug Discovery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. AI-driven Drug Discovery Market Challenges
Table 22. Global AI-driven Drug Discovery Sales by Type (K Units)
Table 23. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 24. Global AI-driven Drug Discovery Sales (K Units) by Type (2019-2024)
Table 25. Global AI-driven Drug Discovery Sales Market Share by Type (2019-2024)
Table 26. Global AI-driven Drug Discovery Market Size (M USD) by Type (2019-2024)
Table 27. Global AI-driven Drug Discovery Market Size Share by Type (2019-2024)
Table 28. Global AI-driven Drug Discovery Price (USD/Unit) by Type (2019-2024)
Table 29. Global AI-driven Drug Discovery Sales (K Units) by Application
Table 30. Global AI-driven Drug Discovery Market Size by Application
Table 31. Global AI-driven Drug Discovery Sales by Application (2019-2024) & (K Units)
Table 32. Global AI-driven Drug Discovery Sales Market Share by Application (2019-2024)
Table 33. Global AI-driven Drug Discovery Sales by Application (2019-2024) & (M USD)
Table 34. Global AI-driven Drug Discovery Market Share by Application (2019-2024)
Table 35. Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
Table 36. Global AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 37. Global AI-driven Drug Discovery Sales Market Share by Region (2019-2024)
Table 38. North America AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 39. Europe AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 41. South America AI-driven Drug Discovery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa AI-driven Drug Discovery Sales by Region (2019-2024) & (K Units)
Table 43. Global AI-driven Drug Discovery Production (K Units) by Region (2019-2024)
Table 44. Global AI-driven Drug Discovery Revenue (US$ Million) by Region (2019-2024)
Table 45. Global AI-driven Drug Discovery Revenue Market Share by Region (2019-2024)
Table 46. Global AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Entos AI-driven Drug Discovery Basic Information
Table 52. Entos AI-driven Drug Discovery Product Overview
Table 53. Entos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Entos Business Overview
Table 55. Entos AI-driven Drug Discovery SWOT Analysis
Table 56. Entos Recent Developments
Table 57. Selvita AI-driven Drug Discovery Basic Information
Table 58. Selvita AI-driven Drug Discovery Product Overview
Table 59. Selvita AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Selvita Business Overview
Table 61. Selvita AI-driven Drug Discovery SWOT Analysis
Table 62. Selvita Recent Developments
Table 63. Benevolent AI-driven Drug Discovery Basic Information
Table 64. Benevolent AI-driven Drug Discovery Product Overview
Table 65. Benevolent AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Benevolent AI-driven Drug Discovery SWOT Analysis
Table 67. Benevolent Business Overview
Table 68. Benevolent Recent Developments
Table 69. Exscientia AI-driven Drug Discovery Basic Information
Table 70. Exscientia AI-driven Drug Discovery Product Overview
Table 71. Exscientia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Exscientia Business Overview
Table 73. Exscientia Recent Developments
Table 74. Euretos AI-driven Drug Discovery Basic Information
Table 75. Euretos AI-driven Drug Discovery Product Overview
Table 76. Euretos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Euretos Business Overview
Table 78. Euretos Recent Developments
Table 79. Illumina with AstraZeneca AI-driven Drug Discovery Basic Information
Table 80. Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
Table 81. Illumina with AstraZeneca AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Illumina with AstraZeneca Business Overview
Table 83. Illumina with AstraZeneca Recent Developments
Table 84. Novo Nordisk with Microsoft AI-driven Drug Discovery Basic Information
Table 85. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
Table 86. Novo Nordisk with Microsoft AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Novo Nordisk with Microsoft Business Overview
Table 88. Novo Nordisk with Microsoft Recent Developments
Table 89. Iktos AI-driven Drug Discovery Basic Information
Table 90. Iktos AI-driven Drug Discovery Product Overview
Table 91. Iktos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Iktos Business Overview
Table 93. Iktos Recent Developments
Table 94. Aqemia AI-driven Drug Discovery Basic Information
Table 95. Aqemia AI-driven Drug Discovery Product Overview
Table 96. Aqemia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Aqemia Business Overview
Table 98. Aqemia Recent Developments
Table 99. Zephyr AI AI-driven Drug Discovery Basic Information
Table 100. Zephyr AI AI-driven Drug Discovery Product Overview
Table 101. Zephyr AI AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Zephyr AI Business Overview
Table 103. Zephyr AI Recent Developments
Table 104. Cyclicarx AI-driven Drug Discovery Basic Information
Table 105. Cyclicarx AI-driven Drug Discovery Product Overview
Table 106. Cyclicarx AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Cyclicarx Business Overview
Table 108. Cyclicarx Recent Developments
Table 109. Eli Lilly AI-driven Drug Discovery Basic Information
Table 110. Eli Lilly AI-driven Drug Discovery Product Overview
Table 111. Eli Lilly AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Terray Therapeutics AI-driven Drug Discovery Basic Information
Table 115. Terray Therapeutics AI-driven Drug Discovery Product Overview
Table 116. Terray Therapeutics AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Terray Therapeutics Business Overview
Table 118. Terray Therapeutics Recent Developments
Table 119. Ardigen AI-driven Drug Discovery Basic Information
Table 120. Ardigen AI-driven Drug Discovery Product Overview
Table 121. Ardigen AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Ardigen Business Overview
Table 123. Ardigen Recent Developments
Table 124. ReviveMed AI-driven Drug Discovery Basic Information
Table 125. ReviveMed AI-driven Drug Discovery Product Overview
Table 126. ReviveMed AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. ReviveMed Business Overview
Table 128. ReviveMed Recent Developments
Table 129. Insilico Medicine AI-driven Drug Discovery Basic Information
Table 130. Insilico Medicine AI-driven Drug Discovery Product Overview
Table 131. Insilico Medicine AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Insilico Medicine Business Overview
Table 133. Insilico Medicine Recent Developments
Table 134. XtalPi AI-driven Drug Discovery Basic Information
Table 135. XtalPi AI-driven Drug Discovery Product Overview
Table 136. XtalPi AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. XtalPi Business Overview
Table 138. XtalPi Recent Developments
Table 139. MindRank AI-driven Drug Discovery Basic Information
Table 140. MindRank AI-driven Drug Discovery Product Overview
Table 141. MindRank AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. MindRank Business Overview
Table 143. MindRank Recent Developments
Table 144. DP Technology AI-driven Drug Discovery Basic Information
Table 145. DP Technology AI-driven Drug Discovery Product Overview
Table 146. DP Technology AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. DP Technology Business Overview
Table 148. DP Technology Recent Developments
Table 149. Global AI-driven Drug Discovery Sales Forecast by Region (2025-2032) & (K Units)
Table 150. Global AI-driven Drug Discovery Market Size Forecast by Region (2025-2032) & (M USD)
Table 151. North America AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 152. North America AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 153. Europe AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 154. Europe AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 155. Asia Pacific AI-driven Drug Discovery Sales Forecast by Region (2025-2032) & (K Units)
Table 156. Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region (2025-2032) & (M USD)
Table 157. South America AI-driven Drug Discovery Sales Forecast by Country (2025-2032) & (K Units)
Table 158. South America AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 159. Middle East and Africa AI-driven Drug Discovery Consumption Forecast by Country (2025-2032) & (Units)
Table 160. Middle East and Africa AI-driven Drug Discovery Market Size Forecast by Country (2025-2032) & (M USD)
Table 161. Global AI-driven Drug Discovery Sales Forecast by Type (2025-2032) & (K Units)
Table 162. Global AI-driven Drug Discovery Market Size Forecast by Type (2025-2032) & (M USD)
Table 163. Global AI-driven Drug Discovery Price Forecast by Type (2025-2032) & (USD/Unit)
Table 164. Global AI-driven Drug Discovery Sales (K Units) Forecast by Application (2025-2032)
Table 165. Global AI-driven Drug Discovery Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of AI-driven Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI-driven Drug Discovery Market Size (M USD), 2019-2032
Figure 5. Global AI-driven Drug Discovery Market Size (M USD) (2019-2032)
Figure 6. Global AI-driven Drug Discovery Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AI-driven Drug Discovery Market Size by Country (M USD)
Figure 11. AI-driven Drug Discovery Sales Share by Manufacturers in 2023
Figure 12. Global AI-driven Drug Discovery Revenue Share by Manufacturers in 2023
Figure 13. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by AI-driven Drug Discovery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global AI-driven Drug Discovery Market Share by Type
Figure 18. Sales Market Share of AI-driven Drug Discovery by Type (2019-2024)
Figure 19. Sales Market Share of AI-driven Drug Discovery by Type in 2023
Figure 20. Market Size Share of AI-driven Drug Discovery by Type (2019-2024)
Figure 21. Market Size Market Share of AI-driven Drug Discovery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI-driven Drug Discovery Market Share by Application
Figure 24. Global AI-driven Drug Discovery Sales Market Share by Application (2019-2024)
Figure 25. Global AI-driven Drug Discovery Sales Market Share by Application in 2023
Figure 26. Global AI-driven Drug Discovery Market Share by Application (2019-2024)
Figure 27. Global AI-driven Drug Discovery Market Share by Application in 2023
Figure 28. Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
Figure 29. Global AI-driven Drug Discovery Sales Market Share by Region (2019-2024)
Figure 30. North America AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 32. U.S. AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada AI-driven Drug Discovery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico AI-driven Drug Discovery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 37. Germany AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific AI-driven Drug Discovery Sales Market Share by Region in 2023
Figure 44. China AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 50. South America AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 51. Brazil AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa AI-driven Drug Discovery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global AI-driven Drug Discovery Production Market Share by Region (2019-2024)
Figure 62. North America AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 65. China AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 66. Global AI-driven Drug Discovery Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global AI-driven Drug Discovery Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global AI-driven Drug Discovery Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global AI-driven Drug Discovery Market Share Forecast by Type (2025-2032)
Figure 70. Global AI-driven Drug Discovery Sales Forecast by Application (2025-2032)
Figure 71. Global AI-driven Drug Discovery Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of AI-driven Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI-driven Drug Discovery Market Size (M USD), 2019-2032
Figure 5. Global AI-driven Drug Discovery Market Size (M USD) (2019-2032)
Figure 6. Global AI-driven Drug Discovery Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AI-driven Drug Discovery Market Size by Country (M USD)
Figure 11. AI-driven Drug Discovery Sales Share by Manufacturers in 2023
Figure 12. Global AI-driven Drug Discovery Revenue Share by Manufacturers in 2023
Figure 13. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by AI-driven Drug Discovery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global AI-driven Drug Discovery Market Share by Type
Figure 18. Sales Market Share of AI-driven Drug Discovery by Type (2019-2024)
Figure 19. Sales Market Share of AI-driven Drug Discovery by Type in 2023
Figure 20. Market Size Share of AI-driven Drug Discovery by Type (2019-2024)
Figure 21. Market Size Market Share of AI-driven Drug Discovery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global AI-driven Drug Discovery Market Share by Application
Figure 24. Global AI-driven Drug Discovery Sales Market Share by Application (2019-2024)
Figure 25. Global AI-driven Drug Discovery Sales Market Share by Application in 2023
Figure 26. Global AI-driven Drug Discovery Market Share by Application (2019-2024)
Figure 27. Global AI-driven Drug Discovery Market Share by Application in 2023
Figure 28. Global AI-driven Drug Discovery Sales Growth Rate by Application (2019-2024)
Figure 29. Global AI-driven Drug Discovery Sales Market Share by Region (2019-2024)
Figure 30. North America AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 32. U.S. AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada AI-driven Drug Discovery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico AI-driven Drug Discovery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 37. Germany AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific AI-driven Drug Discovery Sales Market Share by Region in 2023
Figure 44. China AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 50. South America AI-driven Drug Discovery Sales Market Share by Country in 2023
Figure 51. Brazil AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa AI-driven Drug Discovery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa AI-driven Drug Discovery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global AI-driven Drug Discovery Production Market Share by Region (2019-2024)
Figure 62. North America AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 65. China AI-driven Drug Discovery Production (K Units) Growth Rate (2019-2024)
Figure 66. Global AI-driven Drug Discovery Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global AI-driven Drug Discovery Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global AI-driven Drug Discovery Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global AI-driven Drug Discovery Market Share Forecast by Type (2025-2032)
Figure 70. Global AI-driven Drug Discovery Sales Forecast by Application (2025-2032)
Figure 71. Global AI-driven Drug Discovery Market Share Forecast by Application (2025-2032)
